Regulus Therapeutics
RGLS
#7012
Rank
A$0.84 B
Marketcap
A$12.21
Share price
0.00%
Change (1 day)
397.29%
Change (1 year)

Market capitalization of Regulus Therapeutics (RGLS)

Last known market cap: A$0.84 Billion

As of January 2026 Regulus Therapeutics has a market cap of A$0.84 Billion. This makes Regulus Therapeutics the world's 7012th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Regulus Therapeutics from 2012 to 2025

End of year Market Cap

Year Marketcap Change
2025A$0.84 B420.11%
2024A$0.16 B326.84%
2023A$37.99 M12.07%
2022A$33.9 M-46.54%
2021A$63.42 M-43.11%
2020A$0.11 B317.29%
2019A$26.71 M129.37%
2018A$11.64 M-91.59%
2017A$0.13 B-16.17%
2016A$0.16 B-73.8%
2015A$0.63 B-34.28%
2014A$0.95 B177.08%
2013A$0.34 B59.38%
2012A$0.21 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
GlaxoSmithKline
GSK
A$153.57 B 18,069.55%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sanofi
SNY
A$173.58 B 20,437.54%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
A$37.16 B 4,296.52%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$446.89 B 52,773.44%๐Ÿ‡ฌ๐Ÿ‡ง UK
Alnylam Pharmaceuticals
ALNY
A$72.51 B 8,479.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
A$0.21 B-74.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$173.66 B 20,446.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
A$4.45 B 427.07%๐Ÿ‡บ๐Ÿ‡ธ USA